SEC Form 4 · accession 0001209191-16-094490
NOVAVAX INC · NVAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory M Glenn
Officer — SVP, Research and Development
Period of report
Jan 31, 2016
Accepted (ET)
Feb 1, 2016 · 5:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000694
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 31, 2016 | P | 2,369 | $4.38 | A | 2,427 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 2,369 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on January 31, 2016.